Standex International (SXI) Earnings: Q1 Fiscal 2027 Results and Next Report Date

The quarter ended September 30, 2026 and Standex International published the results on October 29, 2026. Revenue and diluted EPS are shown against Q1 fiscal 2026, the same quarter a year earlier, which takes seasonal swings out of the comparison. Standex International reports EPS two ways: GAAP, under the accounting rules every US filer follows, and adjusted EPS from continuing operations, which leaves out items the company considers outside its operating results. The release reconciles the two, and when they diverge, the reconciliation says why.

• Standex's fiscal year ends June 30, so Q1 fiscal 2027 is the quarter ended September 30, 2026.
• Standex sold its Federal Industries display merchandising business on March 5, 2026 and realigned its segments, combining Hydraulics with Engraving and renaming Engineering Technologies as Aerospace & Defense. Prior periods were revised; the Other row is the divested Federal business.
• GAAP EPS above is diluted EPS on total income attributable to Standex. Diluted EPS from continuing operations was $1.99.

Source: Standex Q1 fiscal 2027 results, October 29, 2026. Also in the Form 10-Q for the quarter ended September 30, 2026. Figures as reported; checked against the release on November 10, 2026.

How Standex International splits revenue in its own release, under its own labels, for Q1 fiscal 2027 against Q1 fiscal 2026. Indented lines are parts of the line above them.

• Standex International's Electronics revenue was $141 million in Q1 fiscal 2027, up 27% from $111 million in Q1 fiscal 2026, 60% of total revenue.
• Standex International's Aerospace & Defense revenue was $31.4 million in Q1 fiscal 2027, up 5% from $29.9 million in Q1 fiscal 2026, 14% of total revenue.
• Standex International's Scientific revenue was $19.8 million in Q1 fiscal 2027, up 2% from $19.5 million in Q1 fiscal 2026, 9% of total revenue.
• Standex International's Engraving & Hydraulics revenue was $40.9 million in Q1 fiscal 2027, down 15% from $48.0 million in Q1 fiscal 2026, 18% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

From the earnings release

In its Q1 fiscal 2027 release, Standex International said:

“For fiscal year 2027, the Company is raising its outlook to high-single digits total sales growth, from mid-to-high single digits previously.”

“The Company now anticipates organic sales to increase by more than $100 million in fiscal year 2027.”

“The Company expects higher sales and adjusted operating margin expansion to drive high teens growth in adjusted earnings per share.”

“In fiscal second quarter 2027, on a year-on-year basis, the Company expects moderately higher revenue and adjusted operating margin.”

Source: Standex Q1 fiscal 2027 release, Oct 29, 2026.

This is the company's own guidance as of Oct 29, 2026, quoted as given. Walnut does not make forecasts of its own. Analyst estimates for the coming quarters are on the SXI forecast page.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

Net sales and diluted EPS on total income attributable to Standex, each as first reported in that quarter's release. Q3 fiscal 2026 EPS includes the gain on the sale of Federal Industries.

Standex International's next report is expected around January 28, 2027, a date estimated from its reporting history that the company has not yet confirmed. This page will show Q1 fiscal 2027 until those results are out and have been checked against the release.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q1 fiscal 2027 (this page), reported Oct 29, 2026

Standex International had net sales of $232.6 million in Q1 fiscal 2027, up 7.0% from $217.4 million, and up 12.4% organically. Electronics was $140.5 million, or 60% of sales, up 27.1%. Engraving & Hydraulics was $40.9 million, down 14.9%, Aerospace & Defense $31.4 million, up 5.1%, and Scientific $19.8 million, up 1.8%. The year-ago quarter also included $9.5 million from the Federal Industries business Standex sold in March 2026. (Standex Q1 fiscal 2027 release (8-K Exhibit 99), Oct 29, 2026; Standex Form 10-Q, Q1 fiscal 2027, Oct 30, 2026)

Standex's Electronics group makes sensing and switching technologies, high precision instrument transformers, and high reliability magnetic power conversion and measurement components and assemblies. Its organic growth of 29.5% came from sales into fast growth markets, strong general industrial markets and new products, and the segment booked record orders of about $173 million. (Standex Form 10-K, fiscal 2026, Aug 14, 2026; Standex Q1 fiscal 2027 release (8-K Exhibit 99), Oct 29, 2026)

Engraving & Hydraulics fell on an organic decline of 15.7% from softness in the North American automotive market. Aerospace & Defense grew on project activity in space and defense markets, and Scientific on pricing and a slight market recovery. (Standex Q1 fiscal 2027 release (8-K Exhibit 99), Oct 29, 2026)

By location, Standex's United States operations produced $129.1 million of net sales and Asia Pacific $73.1 million, up from $56.4 million a year earlier, while EMEA fell to $28.7 million from $32.6 million. Sales from fast growth markets were about $78 million in the quarter. (Standex Form 10-Q, Q1 fiscal 2027, Oct 30, 2026; Standex Q1 fiscal 2027 release (8-K Exhibit 99), Oct 29, 2026)

Standex's backlog realizable under one year rose $91.7 million, or 37.3%, to $338.0 million at September 30, 2026, which it attributed mainly to fast growth end markets. Total backlog was $420.9 million, of which Electronics held $239.6 million. Company-wide orders were a record of about $273 million, a book-to-bill of 1.17. (Standex Form 10-Q, Q1 fiscal 2027, Oct 30, 2026; Standex Q1 fiscal 2027 release (8-K Exhibit 99), Oct 29, 2026)

Standex International's diluted EPS from continuing operations was $1.99 in Q1 fiscal 2027, against $1.25, and adjusted EPS from continuing operations was $2.41, up 21.1% from $1.99. The adjustments add back restructuring charges ($0.06 a share), acquisition-related costs ($0.02), amortization of acquired intangible assets ($0.27) and a loss on sale of business ($0.06). Including discontinued operations, diluted EPS was $1.98. (Standex Q1 fiscal 2027 release (8-K Exhibit 99), Oct 29, 2026)

Standex's restructuring costs fell to $1.0 million from $6.0 million, which helped GAAP operating margin rise to 17.4% from 13.6%. Interest expense fell to $7.2 million from $8.9 million. The effective tax rate from continuing operations was 24.7%, against 24.6% a year earlier. (Standex Q1 fiscal 2027 release (8-K Exhibit 99), Oct 29, 2026; Standex Form 10-Q, Q1 fiscal 2027, Oct 30, 2026)

Diluted shares were 12,146 thousand, against 12,047 thousand. Standex did not repurchase shares under its program in the quarter. On July 2, 2026 it paid about $64.0 million to buy the remaining 9.90% of Narayan from its noncontrolling holders, so no income is now attributed to a redeemable noncontrolling interest ($739 thousand a year earlier). On October 27, 2026 its board authorized a new $100 million share repurchase. (Standex Q1 fiscal 2027 release (8-K Exhibit 99), Oct 29, 2026; Standex Form 10-Q, Q1 fiscal 2027, Oct 30, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

Standex International gives a qualitative outlook, not numeric ranges. For fiscal 2027 it raised its outlook to high-single digits total sales growth, from mid-to-high single digits, and now expects organic sales to increase by more than $100 million and adjusted EPS to grow in the high teens. It expects sales from fast growth markets to grow more than 20% to more than $315 million. (Standex Q1 fiscal 2027 release (8-K Exhibit 99), Oct 29, 2026)

For fiscal Q2 2027, Standex expects moderately higher revenue and adjusted operating margin year on year, slightly higher revenue and similar adjusted operating margin sequentially, and interest expense of $7.0 million to $7.5 million. It expects fiscal 2027 capital expenditures of $45 million to $55 million, mostly for capacity in Standex Electronics Grid. (Standex Q1 fiscal 2027 release (8-K Exhibit 99), Oct 29, 2026)

A consensus figure is the average of the models published by the analysts who cover Standex International, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones Standex International's own release and filings put weight on for Q1 fiscal 2027, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning SXI is on is SXI a buy or a sell?, what analysts expect next is on the SXI forecast, and what the company does is on the Standex International (SXI) stock page.

Every number on this page can be traced to a document Standex International published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.